BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6445232)

  • 1. Differential responsiveness to MIs locus antigens in graft-versus-host and host-versus-graft reactions.
    Wolters EA; Brons NH; van der Kwast TH; Benner R
    Cell Immunol; 1980 May; 51(2):215-25. PubMed ID: 6445232
    [No Abstract]   [Full Text] [Related]  

  • 2. Spleen cell transplantation in mice: influence of non-H-2 M locus on graft-vs.-host and host-vs.-graft reactions.
    Huber B; Peña-Martinez J; Festenstein H
    Transplant Proc; 1973 Dec; 5(4):1373-5. PubMed ID: 4149546
    [No Abstract]   [Full Text] [Related]  

  • 3. Enhancement of the mixed lymphocyte reaction by in vivo treatment of stimulator spleen cells with anti-IgD antibody.
    Ryan JJ; Mond JJ; Finkelman FD; Scher I
    J Immunol; 1983 Jun; 130(6):2534-41. PubMed ID: 6222106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of a graft-versus-host reaction between mice compatible at the H-2 locus.
    Salaman MH; Wedderburn N; Festenstein H; Huber B
    Transplantation; 1973 Jul; 16(1):29-31. PubMed ID: 4145961
    [No Abstract]   [Full Text] [Related]  

  • 5. Relationship between proliferative and effector phases of the mixed lymphocyte reaction and graft-vs-host reaction.
    Howe M; Berman L; Cohen L
    J Immunol; 1973 Oct; 111(4):1243-9. PubMed ID: 4147022
    [No Abstract]   [Full Text] [Related]  

  • 6. Differential responsiveness to H-2-subregion-coded antigens in graft versus host and host versus graft reactions.
    Wolters EA; van der Kwast TH; Odijk LM; Benner R
    Cell Immunol; 1981 Jan; 57(2):389-99. PubMed ID: 6971165
    [No Abstract]   [Full Text] [Related]  

  • 7. Graft-versus-host reaction. Influence of genetic background in donor-recipient pairs incompatible for major histocompatibility complex (MHC).
    Abauf N; Halle-Pannenko O; Mathe G
    Transplantation; 1977 Jul; 24(1):74-7. PubMed ID: 18821
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of T cell depletion from spleen cell allografts on graft-versus-host disease and long-term immune reconstitution in H-2 haplotype-identical murine combinations.
    Tokuda N; Mayumi H; Sakumoto M; Himeno K; Tomita Y; Nomoto K
    Immunobiology; 1989 Oct; 179(4-5):328-41. PubMed ID: 2515151
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of an established graft-versus-host reaction in AKR mice by adoptive immunotherapy.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):634-6. PubMed ID: 234788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect on graft-versus-host response of donor mouse preimmunization with M-locus and DBA/2 (DAG) antigens [proceedings].
    Matossian-Rogers A; Festenstein H
    Folia Biol (Praha); 1976; 22(6):428. PubMed ID: 12031
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on non-H-2-linked lymphocyte-activating determinants. IV. Ontogeny of the Mls product on murine B cells.
    Ahmed A; Scher I; Sell KW
    Cell Immunol; 1977 Apr; 30(1):122-34. PubMed ID: 67901
    [No Abstract]   [Full Text] [Related]  

  • 12. Graft versus leukemia without fatal graft-versus-host disease in AKR mice.
    Chester SJ; Esparza AR; Albala MM
    Cancer Res; 1975 Mar; 35(3):637-9. PubMed ID: 234789
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The nature of tolerance in adult recipient mice made tolerant of alloantigens with supralethal irradiation followed by syngeneic bone marrow cell transplantation plus injection of F1 spleen cells.
    Tomita Y; Himeno K; Mayumi H; Tokuda N; Nomoto K
    Transplantation; 1989 Jun; 47(6):1021-9. PubMed ID: 2660340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitigation of graft-versus-host disease in mice by treatment of donors with bacterial endotoxin.
    Rose WC; Rodey GE; Rimm AA; Truitt RL; Bortin MM
    Exp Hematol; 1976 Mar; 4(2):90-6. PubMed ID: 4335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H-2-restricted recognition of minor histocompatibility antigens in delayed type hypersensitivity.
    van der Kwast TH
    J Immunogenet; 1980 Aug; 7(4):315-24. PubMed ID: 6935297
    [No Abstract]   [Full Text] [Related]  

  • 16. Synergism of T lymphocyte subsets in the response to Mls-locus coded antigens during graft-versus-host reaction.
    Bril H; Molendijk-Lok BD; Hussaarts-Odijk LM; Benner R
    Cell Immunol; 1984 Feb; 83(2):370-8. PubMed ID: 6607131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Graft versus leukemia. 3. Apparent independent anthost and antileukemia activity of transplanted immunocompetent cells.
    Bortin MM; Rimm AA; Saltzstein EC; Rodey GE
    Transplantation; 1973 Sep; 16(3):182-8. PubMed ID: 4147030
    [No Abstract]   [Full Text] [Related]  

  • 18. Heterogeneity of mouse Thy 1.2 antigen expression revealed by monoclonal antibodies.
    Del Guercio P; Motta I; Metezeau P; Brugere S; Perret R; Truffa-Bachi P
    Cell Immunol; 1982 Oct; 73(1):72-82. PubMed ID: 6129926
    [No Abstract]   [Full Text] [Related]  

  • 19. [Spleen reactivity after BCG treatement: test and strain dependency of the response].
    Florentin I; Orbach-Arbouys S
    Ann Immunol (Paris); 1977; 128(1-2):271-2. PubMed ID: 15497
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Weak graft-versus-host response of CBA lymphocytes against the H-2-identical strain C3H.
    Lilliehöök B; Blomgren H
    Scand J Immunol; 1974; 3(5):637-44. PubMed ID: 4153552
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.